Chemical Property of 6,7-Dimethyl-2-phenylquinoxaline
Chemical Property:
- Vapor Pressure:3.42E-06mmHg at 25°C
- Melting Point:121 °C
- Boiling Point:398.3°Cat760mmHg
- PKA:1.29±0.30(Predicted)
- Flash Point:172.4°C
- PSA:25.78000
- Density:1.127g/cm3
- LogP:3.91360
- Storage Temp.:−20°C
- Solubility.:Chloroform (Slightly), Ethyl Acetate (Slightly)
- XLogP3:3.6
- Hydrogen Bond Donor Count:0
- Hydrogen Bond Acceptor Count:2
- Rotatable Bond Count:1
- Exact Mass:234.115698455
- Heavy Atom Count:18
- Complexity:272
- Purity/Quality:
-
99%, *data from raw suppliers
AG 1295 *data from reagent suppliers
Safty Information:
- Pictogram(s):
- Hazard Codes:
- Safety Statements:
22-24/25
- MSDS Files:
-
SDS file from LookChem
Useful:
- Canonical SMILES:CC1=CC2=NC=C(N=C2C=C1C)C3=CC=CC=C3
-
Description
Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. Tyrphostins are a class of antiproliferative compounds which act as PTK blockers. PTK inhibitors specific for platelet-derived growth factor (PDGF) receptor kinase could help in the treatment of atherosclerosis, restenosis, pulmonary fibrosis, and gliomas. AG-1295 is a quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGF receptor kinase in vitro and in Swiss 3T3 cells (IC50s range from 0.3-1 μM). It inhibits PDGF-stimulated DNA synthesis with an IC50 value of 2.5 μM without affecting activity of the EGF receptor.
-
Uses
AG-1295 is a protein tyrosine kinase inhibitor. Antiproliferative agent used in the treatment of atherosclerosis, pulmonary fibrosis, and gliomas.